Skip to main content

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...


Top Series in United States

Showing 1 - 12 of 12 results for “se epstein
Skip side bar filters
  • Hypertrophic Cardiomyopathy

    The Therapeutic Role of Calcium Antagonists

    Edited by M. Kaltenbach, S.E. Epstein ...
    Series series Medicine (R0)
    First described in 1907 by Schicke but recognized as a clinical entity only as recently as 1958, when Teare published the pathologic findings in patients with hypertrophic cardiomyopathy (HeM), an explosion of knowledge about this fascinating disease has occurred, which has caused a profound evolution of our understanding of its broad pathophysiologic and clinical spectrum. Progress has been ... Read more

    $89.99 USD

People who read this also enjoyed

  • Hypertension and You

    Old Drugs, New Drugs, and the Right Drugs for Your High Blood Pressure

    Many of the nearly 70 million Americans with hypertension (high blood pressure) would like to bring it under control through lifestyle changes such as losing weight, cutting back on salt, exercising, or reducing stress. But, like it or not, most will require medication to get their blood pressure where it needs to be. The good news is that we have many excellent blood pressure medications which, ... Read more

    $14.49 USD

  • Erectile Dysfunction as a Cardiovascular Impairment

    by Robert Fried ...
    Erectile Dysfunction as a Cardiovascular Impairment organizes and summarizes the many aspects of biology and metabolism in cardiovascular and sexual function. Coverage includes how blood vessels are discovered to work, their role in hypertension, atherosclerosis, type-2 diabetes, oxidative stress, metabolic syndrome, and erectile dysfunction. - Unifies medical disorders linked to cardiovascular ... Read more

    $115.19 USD

  • Heart Failure

    Series Book 243 - Handbook of Experimental Pharmacology
    This special issue of the Handbook of Experimental Pharmacology on Heart Failure covers the entire spectrum of the field, from the current understanding and definitions of heart failure, to epidemiology and the importance of co-morbidities, clinical trial design and biomarkers, as well as imaging technologies. The main focus of this book is to review current and emerging heart failure therapies ... Read more

    $242.99 USD

  • The Beta-Blocker Story

    Getting It Right

    The idea of using beta-blockers as a treatment for ventricular fibrillation occurred to James Black over 60 years ago. He developed propranolol and cimetidine, among other pharmacologic agents, work for which he won the Nobel Prize in 1988. Beta-blockers were reported to lower blood pressure by Brian Pritchard in 1964, and he and John Cruickshank wrote Beta-blockers in Clinical Practice, a major ... Read more

    $5.45 USD

  • Pharmacologic Approaches to Heart Failure, An Issue of Heart Failure Clinics

    Series Book Volume 10-4 - The Clinics: Internal Medicine
    This issue of Heart Failure Clinics examines the pharmacologic approaches to heart failure: optimizing established therapy with a look toward future agents. Topics include the pathophysiologic foundation for the pharmacologic treatment of heart failure, treatment of heart failure with reducted ejection fraction and preserved ejection fraction, treatment of acute heart failure, investigational ... Read more

    $75.59 USD

  • Acarbose for the Treatment of Diabetes Mellitus

    Edited by W. Creutzfeldt ...
    New principles for the treatment of diabetes are described in this volume. Experts present experimental and clinical data on treatment with acarbose, an alpha-glucosidase inhibitor that delays absorption of fast carbohydrates. Toxicologic, pharmacologic and metabolic effects of acarbose are discussed. A concluding section on the future aspects of alpha-glucosidase inhibition offers a fair ... Read more

    $89.09 USD

  • Cardiovascular Safety in Drug Development and Therapeutic Use

    New Methodologies and Evolving Regulatory Landscapes

    Series series Medicine (R0)
    At a time when the field of cardiac safety is going through important changes, this unique book provides the rationale for, and cutting-edge explanations of, new regulatory landscapes that will likely govern cardiac safety assessments globally for the foreseeable future. Exposure-response modeling is already being accepted by regulatory agencies in lieu of the traditional Thorough QT/QTc Study, ... Read more

    $71.99 USD

  • Pharmacologic Trends of Heart Failure

    Edited by Hector O. Ventura ...
    Series series Medicine (R0)
    This volume reviews potential future therapies for heart failure, with a particular focus on ambulatory acute decompensated heart failure and the transitions from therapies in the acute setting to chronic management.Although in the developed world the incidence of and mortality from coronary heart disease and stroke have been declining over the last 15 years, heart failure is increasing in ... Read more

    $62.99 USD

  • Stem Cell and Gene Therapy for Cardiovascular Disease

    Stem Cell and Gene Therapy for Cardiovascular Disease is a state-of-the-art reference that combines, in one place, the breadth and depth of information available on the topic. As stem cell and gene therapies are the most cutting-edge therapies currently available for patients with heart failure, each section of the book provides information on medical trials from contributors and specialists from ... Read more

    $134.99 USD

  • Cardiovascular Pharmacogenetics

    Edited by Martin R. Wilkins ...
    Series series Biomedical and Life Sciences (R0)
    The Human Genome Project was sold to the general public largely on the basis that a complete picture of the structure of human DNA would lead to new and better medicines. These medicines would be better because they would be tailored to individual patients, maximising the chances of a therapeutic response and mi nimising the risks of an adverse event. Taking the idea further, pundits have pre ... Read more

    $287.09 USD

  • Paraoxonase (PON1) in Health and Disease

    Basic and Clinical Aspects

    The paraoxonase or PON family of genes resides on human chromosome 7q2t-22 in the order PONt, PON3 and PON2. PONt was one of the early genes identified as an environmentally relevant gene, in that it is important in determining an individual's sensitivity or resistance to exposure from specific organophosphorus (OP) insecticides. Paraoxonase (PONt) is an A esterase (i. e. , not inhibited by OP ... Read more

    $89.99 USD